Contribution of early administration of GH to the regeneration and beneficial remodeling of the left ventricle in patients with acute myocardial infarction [Contribucion de la administracion precoz de GH a la regeneracion y remodelado favorable del miocardio ventricular izquierdo en pacientes con infarto agudo de miocardio]

Trial Profile

Contribution of early administration of GH to the regeneration and beneficial remodeling of the left ventricle in patients with acute myocardial infarction [Contribucion de la administracion precoz de GH a la regeneracion y remodelado favorable del miocardio ventricular izquierdo en pacientes con infarto agudo de miocardio]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 02 Apr 2012

At a glance

  • Drugs Somatropin (Primary)
  • Indications Myocardial infarction
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms REGENERA
  • Most Recent Events

    • 02 Apr 2012 Planned End Date changed to 12 Aug 2011.
    • 28 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top